Doctor Rebecca Dabbs

Senior Research Officer


Rebecca completed her PhD in 2013 at the University of Wollongong where she investigated the potential of the extracellular chaperone clusterin to act as an immune modulator.

Post-PhD she moved to London to join Professor Chris Drakeley’s group at the London School of Hygiene and Tropical Medicine working on a malaria seroepidemiology program, and helped to establish a seroepidemiology lab in Bahir Dar, Ethiopia.

To combine her interest in immunology, infectious disease and translational research she took up a role as Senior Research Assistant at the Jenner institute (University of Oxford) working on the development of malaria transmission blocking vaccines. Before joining the spin-out company Spybiotech as Lead Scientist to harness the use of the spy-tag spy-catcher system to develop innovative vaccines to target a range of disease candidates.

She has a keen interest in translational research and is currently focused on the development of point of care diagnostics for the quantitative detection of G6PD deficiency, which will allow informed treatment of patients with malaria and help us towards the goal of eliminating malaria.


  • 2019-present: Senior Research Officer, Burnet Institute
  • 2017-2019: Lead Scientist, Spybiotech - Oxford UK
  • 2014-2017: Senior Research Assistant, Jenner Institute at the University of Oxford, UK
  • 2013-2014: Research Officer, London School of Hygiene and Tropical Medicine - London UK


  • 2013: PhD, University of Wollongong
  • 2007: Honours (class I): Bachelors of Biotechnology (Advanced), University of Wollongong

Publications (8)

2018 (2)

2017 (2)

2014 (1)

2013 (1)

  • Extracellular chaperones.
    Rebecca A Dabbs, Amy R Wyatt, Justin J Yerbury, Heath Ecroyd, Mark R Wilson
    Top Curr Chem. 2013 Jul; 328:241-268

2012 (1)

2009 (1)